Levofloxacin Tablet, Film Coated
Product Images NDC 68071-4738

6 FDA label images from Nucare Pharmaceuticals,inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 68071-4738). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4738 1

68071 4738 1
Label for Levofloxacin 500 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The package contains 10 tablets. The label includes warnings, manufacturer details (3 Hetero Labs Limited, India), and storage instructions at controlled temperature 68-77°F. It also displays NDC 68071-4738-1, batch, expiration, and serial number fields along with barcodes and a QR code.*
FDA Label Image

Levofloxacinaddress1 (Levofloxacinaddress1)

FDA Label Image

Levofloxacinaddress2 (Levofloxacinaddress2)

FDA Label Image

Levofloxacinfigure1 (Levofloxacinfigure1)

Levofloxacinfigure1 (Levofloxacinfigure1)
Chemical structure of Levofloxacin showing its molecular framework, including a fluorine atom, ketone group, and other characteristic chemical bonds, accompanied by a notation of half a water molecule as part of the hydrate form.*
FDA Label Image

Levofloxacinfigure2 (Levofloxacinfigure2)

Levofloxacinfigure2 (Levofloxacinfigure2)
A pharmacokinetic line graph showing plasma concentration (mcg/mL) over time (hours) for Levofloxacin 750 mg administered either orally or intravenously over 90 minutes. The graph compares plasma levels following tablet ingestion and IV infusion, illustrating concentration decline over 36 hours.*
FDA Label Image

Levofloxacinfigure3 (Levofloxacinfigure3)

Levofloxacinfigure3 (Levofloxacinfigure3)
A line graph depicting plasma concentration (mcg/mL) over time (hours) for Levofloxacin 500 mg administered orally and intravenously. The graph shows plasma concentration decline from 0 to 36 hours, comparing the two administration routes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.